Six Modeling Approaches, Including Digital Twins, Unlock Complex Bioprocess Data for Optimized Manufacturing

September 20, 2026

BioProcess Online USA

Overview

Six key modeling approaches, with a strong emphasis on digital twins, are presented for effectively leveraging complex bioprocess data. Digital twins provide a comprehensive virtual representation of physical systems, continuously updated with real-time data to offer immense value in biomanufacturing process prediction and optimization. These modeling techniques form the foundation for deeper process understanding, enhanced efficiency, and consistent product quality.

In Depth

Key Findings

Six pivotal modeling approaches have been presented for maximizing the utility of complex bioprocess data, with particular emphasis on the central role of digital twins. These approaches offer a comprehensive virtual representation of physical biomanufacturing processes, continuously updated by real-time data, thereby providing essential information for process prediction, optimization, and control. This promises significant advancements in efficiency, consistency, and quality within biopharmaceutical manufacturing.

Technical/Clinical Details

The six modeling approaches include physics-based models, statistical models, machine learning models, hybrid models, and digital twins, which integrate these individual methods. Digital twins combine these models to analyze real-time data, such as temperature, pH, dissolved oxygen, cell density, and metabolite concentrations, collected from physical processes, and feed this information back into the virtual model. This enables accurate simulation of process behavior and early identification of potential issues or deviations. For example, predictive analytics can recommend parameter adjustments to maintain optimal culture conditions or forecast final product quality attributes in real-time. This capability minimizes variability between production batches and accelerates time-to-market for products.

Background & Context

Biopharmaceutical manufacturing has historically faced significant challenges in data analysis and process control due to its inherent complexity and variability. While the adoption of Process Analytical Technology (PAT) and industry-wide digital transformation (DX) initiatives have led to the generation of vast amounts of data, the effective utilization of this data remains a key requirement. The modeling approaches discussed, particularly digital twins, provide powerful tools to convert this raw data into meaningful insights, enabling data-driven decision-making. This is crucial for building more robust and better-understood manufacturing processes that comply with quality management guidelines such as ICH Q8, Q9, and Q10.

Strategic Significance & Outlook

These modeling approaches, including digital twins, are critically important in shaping the future of biomanufacturing. In the future, these technologies are expected to evolve further, integrating with AI and IoT to realize more autonomous and adaptive smart manufacturing systems. This will lead to reduced development times, lower manufacturing costs, improved product quality, and ultimately, faster delivery of therapeutic drugs to patients. Furthermore, these models are anticipated to serve as a comprehensive digital infrastructure, supporting process design, optimization, and troubleshooting across the entire lifecycle, from early-stage drug development to commercial production.

Source: https://www.bioprocessonline.com/doc/modeling-approaches-that-make-complex-bioprocess-data-useful-0001

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.